Directly observed and standardized treatment in an era of extensively drug-resistant tuberculosis

Clin Infect Dis. 2009 Jun 1;48(11):1632-3; author reply 1633-4. doi: 10.1086/599013.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial
  • Drug Therapy / standards*
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / epidemiology
  • Humans
  • Mycobacterium tuberculosis / drug effects
  • Prevalence

Substances

  • Antitubercular Agents